Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aptose BiosciencesPrevail TherapeuticsReplimune GroupMeiraGTxAvrobio
SymbolNASDAQ:APTONASDAQ:PRVLNASDAQ:REPLNASDAQ:MGTXNASDAQ:AVRO
Price Information
Current Price$5.99$11.72$9.87$11.66$14.87
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$12.00$20.60$24.10$38.33$36.24
% Upside from Price Target100.33% upside75.77% upside144.17% upside228.76% upside143.69% upside
Trade Information
Market Cap$469.82 million$409.22 million$391.74 million$484.52 million$527.85 million
Beta1.64N/A2.732.112.47
Average Volume1,041,974233,834105,473142,411365,903
Sales & Book Value
Annual RevenueN/AN/AN/A$13.29 millionN/A
Price / SalesN/AN/AN/A32.30N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.23 per shareN/A$4.36 per share$5.22 per share$5.87 per share
Price / BookN/AN/AN/A2.23N/A
Profitability
Net Income$-26,280,000.00N/A$-30,830,000.00$-54,750,000.00$-72,960,000.00
EPS($0.52)($2.22)($1.33)($1.65)($2.66)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-411.84%N/A
Return on Equity (ROE)-61.63%N/A-29.68%-33.20%-49.28%
Return on Assets (ROA)-55.07%N/A-24.86%-19.00%-45.81%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.06%0.20%0.11%N/A
Current Ratio17.83%17.05%13.43%5.47%13.96%
Quick Ratio17.83%17.05%13.43%5.47%13.96%
Ownership Information
Institutional Ownership Percentage40.26%79.08%60.10%45.28%68.29%
Insider Ownership Percentage7.34%N/A63.18%17.40%4.70%
Miscellaneous
EmployeesN/A33626849
Shares Outstanding76.27 million34.10 million36.65 million36.82 million36.03 million
Next Earnings Date5/5/2020 (Estimated)6/25/2020 (Estimated)6/26/2020 (Estimated)5/12/2020 (Estimated)5/11/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel